R&D News | pharmaphorum

News

A pioneer of in vivo cell therapy, Umoja has cleared another regulatory milestone by getting fast-track status for its lead blood cancer programme.

News

A phase 3 trial of Vertanical's cannabis extract in back pain has been published, and the results bode well for marketing applications under review.

News

A new £1.2 billion science and technology park was formally opened today in Oxford, in a welcome boost to the UK's life sciences sector.

News

AstraZeneca and Daiichi Sankyo are eyeing regulatory filings for Enhertu in early breast cancer after a second phase 3 trial delivers.

News

Shares in Enanta Pharma were sliding this morning after it reported results of a phase 2b trial of its RSV antiviral zelicapavir.

News

Genmab continues its shift from out-licensing drugs to developing its own drugs with an $8bn deal to buy Merus and its head and neck cancer therapy.